| Renin-angiotensin-system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation |
23 |
| Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study |
19 |
| One year of mepolizumab. Efficacy and safety in real-life in Italy |
17 |
| Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose |
14 |
| BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration |
14 |
| Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease |
14 |
| Use of animal models in IPF research |
12 |
| The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement |
11 |
| Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study |
11 |
| Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: A randomized controlled trial |
11 |
| Arbutin attenuates LPS-induced lung injury via Sirt1/ Nrf2/ NF-kappa Bp65 pathway |
10 |
| Update on the clinical development of gefapixant, a P2X3 receptor antagonist for the treatment of refractory chronic cough |
10 |
| Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies |
10 |
| Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis |
9 |
| Inhalable dry powder prepared from folic acid-conjugated docetaxel liposomes alters pharmacodynamic and pharmacokinetic properties relevant to lung cancer chemotherapy |
9 |
| Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2) |
8 |
| Heterogeneity of cough neurobiology: Clinical implications |
8 |
| Hair analysis to monitor adherence to prescribed chronic inhaler drug therapy in patients with asthma or COPD |
8 |
| Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma |
8 |
| Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations |
8 |
| Inhaled nebulised unfractionated heparin improves lung function in moderate to very severe COPD: A pilot study |
8 |
| Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece |
8 |
| Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension |
8 |
| Ciprofloxacin Dry Powder for Inhalation (ciprofloxacin DPI): Technical design and features of an efficient drug-device combination |
7 |
| Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats |
7 |
| Insight into pulmonary drug delivery: Mechanism of drug deposition to device characterization and regulatory requirements |
7 |
| Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway |
6 |
| Mishandling of pMDI and DPI inhalers in asthma and COPD - Repetitive and non-repetitive errors |
6 |
| Effect of mesenchymal stromal (stem) cell (MSC) transplantation in asthmatic animal models: A systematic review and meta-analysis |
6 |
| GYY4137 attenuates LPS-induced acute lung injury via heme oxygenase-1 modulation |
6 |
| First clinical trials of novel ENaC targeting therapy, SPX- in healthy volunteers and adults with cystic fibrosis |
6 |
| Effect of long-acting beta(2)-agonists olodaterol and formoterol on heart rate and blood pressure in chronic obstructive pulmonary disease patients |
6 |
| Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis |
6 |
| Selectively targeting prostanoid E (EP) receptor-mediated cell signalling pathways: Implications for lung health and disease |
6 |
| Astilbin ameliorates pulmonary fibrosis via blockade of Hedgehog signaling pathway |
5 |
| Effects of fluticasone propionate and budesonide on the expression of immune defense genes in bronchial epithelial cells |
5 |
| The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults |
5 |
| Modeling and optimization of nebulizers' performance in non-invasive ventilation using different fill volumes: Comparative study between vibrating mesh and jet nebulizers |
5 |
| Comorbidities of IPF: How do they impact on prognosis |
5 |
| Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques |
5 |
| Chronic cough and obesity |
5 |
| Prevalence of Arnold nerve reflex in subjects with and without chronic cough: Relevance to Cough Hypersensitivity Syndrome |
5 |
| Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life |
5 |
| Why chronic cough in children is different |
5 |
| Chronic cough in the elderly |
5 |
| Dual role of autophagy/mitophagy in chronic obstructive pulmonary disease |
5 |
| A systematic review of methods of citric acid cough reflex testing |
5 |
| Cardiovascular safety of revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy of chronic obstructive pulmonary disease: Evaluation in phase 3 clinical trials |
4 |
| Comparison of anti-inflammatory mechanisms between doxofylline and theophylline in human monocytes |
4 |
| Airway hypersensitivity induced by eosinophil granule-derived cationic proteins |
4 |
